Balancing Scientific Rigor and Practical Execution in Medical Device Studies

Great to continue the conversation with Neil O’Flaherty following our recent webinar on medical device studies in the U.S.—particularly from the clinical development perspective.

One theme that stood out is the importance of balancing scientific rigor with practical study execution. In medical device development, it can be tempting to overcomplicate study design in pursuit of perfect data, but successful programs often come down to clarity, relevance, and operational feasibility.

A few key takeaways from our discussion:

• Clinical strategy should begin early—well before pivotal studies or regulatory submission planning

• The strongest study designs generate meaningful data while remaining practical and interpretable

• Endpoint selection and study structure should align with both regulatory expectations and real-world clinical use

• Cross-functional collaboration across clinical, regulatory, quality, and technical teams is critical to execution success

• Simplicity in study design can often improve enrollment, compliance, data quality, and overall program efficiency

There’s a real opportunity to rethink how medical device studies are designed and executed—making them more agile, integrated, and fit-for-purpose while still meeting regulatory expectations.

Looking forward to continuing the dialogue and future collaboration.